We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities


Premium NextUp Comedy Technology EIS
NextUp is a Subscription Video On Demand (VOD) service specialising in stand-up comedy. The service was recognised as ‘The Netflix of UK Stand-Up’ by reputed media platform: Engadget. The platform is co-founded by the former Director of Comedy of BBC Worldwide. Daniel Berg is the CEO of the platform and, he is a BAFTA-winning comedy aficionado. Bruce Tuchman (Investor & Special Advisor) is a former President of AMC Networks and MGM Worldwide. Its application has a 4.5-star rating on application store and 4.5 ratings on Trustpilot. NextUp has yielded revenue of £45 LTV and £15 CAC. NextUp seeks to carefully curate the breadth of great comedy and bring it to the audience.
investment: £352,930 target: £300,000 pre-money valuation: £3,692,195
status: Stretch 5 days
to go
More Information
118%
Premium HealthPOD Sport SEIS
HealthPOD is a platform which connects customers to qualified health coaches for on-demand online consultations by making access to experienced support more affordable. The company is in partnership with Shefit and UK's 2nd largest chain: The Gym Group. The application is built by a team nominated for The Drum Mobile Awards 2019. HealthPOD is shortlisted for Health & Wellness Innovation 2019 at Elevate industry awards. The funds raised will be used to develop tech integrations and developing the technology to deliver good customer experience.
investment: £165,080 target: £50,000 pre-money valuation: £1,200,000
status: Stretch 6 days
to go
More Information
330%
Premium Libertine Engineering and Construction
Developing ultra-efficient combustion cycles by replacing a conventional engine's mechanical drivetrain with cleaner and compact electrical components. Libertine have created Free Piston Engines that can operate by using either fossil fuels, or renewable energy. Their products have opportunities to provide benefits in numerous industries and the company has already had discussions with two large automotive firms and OEMs that are interested in utilising the technology. Libertine owns 28 patents and has distributed a license for its product, which is currently generating annual revenue growth of around 90%. Revenues in 2017 totalled £300k.
investment: £710,970 target: £700,001
status: Extended
More Information
102%
KiteEdge's Apex Technology EIS
Kite edge has created a cognitive search service which has been built to specifically meet the needs of asset managers. Individuals can search and set up feeds that draw insight from their specific work (email, news, investment research, internal documents)
investment: £433,000 target: £600,000 pre-money valuation: £2,694,893
status: Funded
More Information
72%
Redevelopment of an old police station and new build of a 3-storey building in the heart of Norbury, London. The site has planning consent for 22 residential units (15 private and 7 shared ownership) and commercial space. The site is a short walk from Norbury station (20 mins to Central London).
investment: £0 target: £0
status: Repaid
More Information
nan%
Probe Technology EIS
Probe has developed microeye to change the way doctors take blood samples. Microeye provides a continous sample from venus blood without removing whole blood. When coupled with Probe’s continumon it gives the clinician continous data showing trends and rate of change.
investment: £233,630 target: £499,968 pre-money valuation: £5,049,066
status: Funded
More Information
47%
A wind turbine's generator currently uses rare-earth magnets which cost £40 per kg, Greenspur have developed innovative generators which use ferrite magnets, an abundantly available material, that cost as little as £1 per kg. The company have made further advancements by removing the gearbox, which has resulted in lower maintenance costs and improved efficiency.
investment: £368,640 target: £500,000 pre-money valuation: £2,340,909
status: Active
More Information
74%
Arca is helping to build the market for property market risk transfer by dealing in derivatives for domestic and commercial properties. Nick Ruddell has held senior roles for the last 30 years with banks and big interdealer brokers.
investment: £676,500 target: £1,500,000 pre-money valuation: £6,000,000
status: Funded
More Information
45%
Kings Mill Development Phase 2 - Interim Equity Housing and Property
An opportunity to invest in the development of a collection of stylish new homes consisting, in total, of 43x, 2 and 3 bed houses and 103x, 1 and 2 bed apartments.   This significant development by Prosperity will bring much needed housing stock to meet the demand from first time buyers as well as from the rental market. The development will be carried out in four phases and a proportion of each phase has been purchased by Prosperity to be sold onto investment buyers.   We are raising equity for the purchase of the site (Subject To Planning) in tranches linked to each Phase. Phase 2 will provide 17x, 2 bed houses and 3x, 3 bed houses, all to be completed within the first 18 months of the build program. All the 2 bed houses are pre-sold to Prosperity generating nearly £2m of sales revenue, and the 3 bed houses will be sold off-plan to local buyers.   The developer has secured the site and is contributing £300k of the total equity, with the remainder coming from CrowdLords Investors. In return for an investment in this Phase, holders of Redeemable Class C shares will receive 45.6% of their share of the projected profit which equates to around 39% of projected Phase 2 net profits, after tax. This will be paid as a capital gain when the shares are redeemed at a price of £1.30 per share, on or before the 28th February 2019.  
investment: £149,299 target: £333,300
status: Active
More Information
45%
PlaqueTec Medical EIS
Cardiovascular Disease is the leading cause of death in the UK, PlaqueTec have developed a Liquid Biopsy System, which allows cardiologists to gain further information from a patient's coronary artery and provide more effective treatment to those affected by the disease.
investment: £1,493,593 target: £2,100,058 pre-money valuation: £12,003,757
status: Active
More Information
71%
Funnel Music is a Music Rights and distribution business, designed to harness the power of modern technology in the music industry. Funnel’s unique business model will disrupt the sector through introducing considerable cost savings to the creation and commercialisation of an artist through Funnel’s ‘Shared Outcome Model’ thus providing sustainable long-term revenues for itself and the artists it engages with.
investment: £85,000 target: £85,000 pre-money valuation: £859,444
status: Extended
More Information
100%
CELLMED Medical EIS
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
investment: £520,294 target: £500,000 pre-money valuation: £2,400,232
status: Stretch
More Information
104%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph